Search hospitals > Florida > Tampa
Tampa General Hospital
Claim this profileTampa, Florida 33606
Global Leader in Tumors
Global Leader in Cancer
Conducts research for Leukemia
Conducts research for Heart Failure
Conducts research for Lymphoma
353 reported clinical trials
35 medical researchers
Summary
Tampa General Hospital is a medical facility located in Tampa, Florida. This center is recognized for care of Tumors, Cancer, Leukemia, Heart Failure, Lymphoma and other specialties. Tampa General Hospital is involved with conducting 353 clinical trials across 542 conditions. There are 35 research doctors associated with this hospital, such as Juan F. Rico, Andrew J. Galligan, Maxim Mokin, PhD, and Sajeel A. Chowdhary.Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Cancer
Global LeaderStage I
Stage IV
Stage II
Top PIs
Juan F. RicoTampa General Hospital6 years of reported clinical research
Expert in Tumors
Studies Cancer
29 reported clinical trials
80 drugs studied
Andrew J. GalliganTampa General Hospital6 years of reported clinical research
Expert in Tumors
Studies Lymphoma
25 reported clinical trials
71 drugs studied
Maxim Mokin, PhDTampa General Hospital3 years of reported clinical research
Studies Ischemic Stroke
Studies Stroke
7 reported clinical trials
12 drugs studied
Sajeel A. ChowdharyBoca Raton Regional Hospital6 years of reported clinical research
Studies Glioblastoma
Studies Cancer
7 reported clinical trials
16 drugs studied
Clinical Trials running at Tampa General Hospital
Breast Cancer
Acute Lymphoblastic Leukemia
Osteosarcoma
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Lymphoma
Stroke
Heart Failure
Brain Tumor
Ovarian Cancer
Giredestrant + Everolimus
for Advanced or Metastatic Breast Cancer
This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the physician's choice of endocrine therapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer who have had previous treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) and endocrine therapy, either in the locally advanced/metastatic or the adjuvant setting.
Recruiting2 awards Phase 37 criteria
Imlunestrant
for Early Breast Cancer
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Recruiting2 awards Phase 36 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Tampa General Hospital?
Tampa General Hospital is a medical facility located in Tampa, Florida. This center is recognized for care of Tumors, Cancer, Leukemia, Heart Failure, Lymphoma and other specialties. Tampa General Hospital is involved with conducting 353 clinical trials across 542 conditions. There are 35 research doctors associated with this hospital, such as Juan F. Rico, Andrew J. Galligan, Maxim Mokin, PhD, and Sajeel A. Chowdhary.
Where is Tampa General Hospital located?
**Directions to Tampa General Hospital, Tampa, Florida:**
- From I-275, exit at 44 or 45A.
- Follow signs for Ashley Dr., then turn right onto Kennedy Blvd.
- Look for Hospital (H) signs and turn left onto S. Hyde Park Ave. to arrive at the hospital.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Tampa General Hospital, contact the following departments:
- **Patient Financial Assistance**: For estimates on hospital services, call 813-844-8084, Monday - Friday, 8 a.m. - 4:30 p.m.
- **Billing & Insurance**: Email mybill@tgh.org or call 813-844-7291, Monday - Friday, 8 a.m. - 4:30 p.m.
- **MyChart Users**: Submit billing questions via MyChart by clicking “Billing” then “See Account Detail”.
For insurance-specific inquiries, contact your insurance provider using the phone number on your billing notice.
What insurance does Tampa General Hospital accept?
Tampa General Hospital accepts a wide range of insurance plans, including but not limited to Medicare Supplement plans, commercial plans (e.g., Florida Hospital Healthcare System, Holland America Cruise Line, Private Healthcare Systems, Inc.), Medicare Advantage Plans (e.g., BaycarePlus Medicare Advantage), Governmental Payors (e.g., Hillsborough County Health Plan, Humana Military Healthcare Services), Health Exchange Plans (e.g., Molina Healthcare of Florida, Inc.), and Medicaid HMO Plans (e.g., Molina Healthcare of Florida, Inc., Magellan Complete Care of Florida). They are committed to transparency in coverage, offering detailed cost information for both in-network and out-of-network healthcare services on their website.
What awards or recognition has Tampa General Hospital received?
Tampa General Hospital is celebrated for its excellence, featuring on the 2022 Fortune/Merative 100 Top Hospitals list. It has been acknowledged by Newsweek as one of America's Greatest Workplaces for Women and Diversity in 2023. Additionally, it has earned the Collaborative Just Culture Program® recognition, highlighting its dedication to patient safety and high-quality healthcare.